Table 4.
Pretreatment and posttreatment patient outcomes
| POQ |
PCS | ISI | Pain NRS | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Program | MOB | ADL | VIT | NA | Fear | Total | Total | Total | Average | |
| ABQ | Pretreatment | 23.86 (9.94) | 9.94 (10.11) | 19.15 (5.43) | 27.10 (11.88) | 9.75 (4.95) | 96.55 (31.45) | 28.33 (13.02) | 17.43 (7.70) | 6.74 (1.53) |
| Posttreatment | 17.04 (10.02) | 6.35 (8.35) | 13.60 (5.42) | 21.53 (11.50) | 5.50 (3.88) | 69.56 (31.81) | 18.65 (12.04) | 15.31 (7.64) | 5.53 (1.82) | |
| t (df)* | 7.36 (116)* | 4.17 (116)* | 11.01 (116)* | 5.13 (116)* | 10.31 (116)* | 9.19 (116)* | 8.32 (116)* | 2.98 (116)* | 7.72 (116)* | |
| CLE | Pretreatment | 25.73 (8.25) | 10.70 (9.75) | 19.93 (4.73) | 24.18 (11.03) | 10.79 (3.38) | 98.07 (28.03) | 28.61 (13.01) | 16.58 (7.32) | 6.75 (1.71) |
| Posttreatment | 21.22 (9.98) | 7.86 (9.40) | 15.05 (4.78) | 18.30 (11.17) | 8.24 (4.22) | 75.63 (30.60) | 17.16 (10.33) | 13.60 (6.51) | 5.59 (2.25) | |
| t (df)* | 4.45 (62)* | 2.80 (62)* | 7.63 (62)* | 4.76 (62)* | 4.71 (62)* | 6.66 (62)* | 7.82 (63)* | 5.86 (61)* | 4.25 (55)* | |
| PS | Pretreatment | 24.18 (9.76) | 10.22 (9.19) | 18.60 (5.28) | 26.12 (11.16) | 9.49 (4.73) | 96.29 (29.85) | 23.13 (12.51) | 16.73 (5.96) | 6.42 (1.69) |
| Posttreatment | 19.14 (9.85) | 8.64 (8.58) | 14.75 (4.89) | 26.44 (10.98) | 6.93 (4.08) | 76.45 (31.28) | 16.52 (10.36) | 14.10 (6.88) | 5.31 (2.02) | |
| t (df)* | 4.00 (116)* | 1.31 (116) | 6.20 (116)* | 3.63 (116) | 4.11 (116)* | 4.88 (116)* | 5.92 (112)* | 4.83 (143)* | 5.15 (115)* | |
| SF | Pretreatment | 23.44 (10.60) | 9.47 (10.23) | 20.80 (4.98) | 26.80 (12.51) | 12.78 (4.61) | 99.51 (31.61) | 28.93 (14.27) | 15.98 (6.63) | 6.22 (2.09) |
| Posttreatment | 18.11 (10.03) | 7.49 (8.16) | 15.42 (5.32) | 21.07 (11.71) | 9.13 (4.64) | 76.11 (31.15) | 19.80 (12.81) | 12.20 (7.01) | 5.00 (2.22) | |
| t (df)* | 3.68 (44)* | 1.64 (44) | 6.71 (44)* | 3.82 (44)* | 4.31 (44)* | 5.99 (44)* | 5.08 (44)* | 5.06 (42)* | 3.93 (44)* | |
| TPA-IN | Pretreatment | 25.37 (9.5) | 14.16 (10.6) | 19.55 (5.07) | 27.92 (11.32) | 11.29 (4.57) | 98.29 (27.9) | 28.07 (12.49) | 17.89 (5.72) | 6.87 (1.53) |
| Posttreatment | 18.49 (10.12) | 9.77 (9.49) | 15.79 (4.89) | 22.97 (12.08) | 8.01 (4.29) | 75.07 (31.47) | 20.2 (13.42) | 14.68 (6.75) | 5.91 (1.79) | |
| t (df)* | 15.55 (363)* | 9.63 (363)* | 12.75 (362)* | 10.07 (362)* | 13.43 (362)* | 17.26 (362)* | 12.96 (363)* | 10.18 (363)* | 10.37 (363)* | |
| TPA-OUT | Pretreatment | 24.24 (9.6) | 15.98 (11.65) | 18.22 (4.13) | 24.71 (12.89) | 12.64 (3.98) | 95.80 (32.71) | 25.57 (13.1) | 17.36 (7.12) | 6.89 (1.34) |
| Posttreatment | 21.73 (10.57) | 12.73 (10.93) | 15.89 (5.55) | 24.07 (12.66) | 9.71 (4.73) | 84.13 (36.37) | 19.87 (13.34) | 15.8 (7.16) | 6.38 (1.83) | |
| t (df)* | 2.45 (44)* | 2.62 (44)* | 3.01 (44)* | 0.51 (44) | 3.94 (44)* | 3.71 (44)* | 2.98 (43)* | 1.63 (44) | 1.94 (44) | |
POQ = Pain Outcomes Questionnaire; PCS = Pain Catastrophizing Scale; ISI = Insomnia Sleep Index; NRS = numeric rating scale; MOB = mobility; ADL = activities of daily living; VIT = vitality; NA = negative affect; ABQ = Albuquerque; CLE = Cleveland; PS = Puget Sound; SF = San Francisco; TPA = Tampa, IN = inpatient; OUT = outpatient; t=t score; df = degrees of freedom.
Paired t test analyses were used to identify statistically significant changes from pretreatment to posttreatment.
*
Significant at 0.05 level.